Catalent Pharma Solutions Appoints New Senior Vice President Of Quality And Regulatory Affairs

Catalent Pharma Solutions Appoints New Senior Vice President of Quality and Regulatory Affairs

Date: 06/25/2009

Somerset, NJ, June 25, 2009  — Catalent Pharma Solutions, Inc. announced the appointment of Sharon Johnson as Senior Vice President of Quality and Regulatory Affairs effective August 2009. Ms. Johnson will be located at Catalent’s corporate headquarters in Somerset, NJ. Ed Thiele, the incumbent in this role, is planning to retire in early 2010.
Ms. Johnson is a Quality professional with more than twenty-five years of experience in the pharmaceutical industry. She joins Catalent after having been Vice President of Quality Assurance for GE Healthcare Biosciences, Medical Diagnostics, in Buckinghamshire, England. Before GE, Ms. Johnson was Quality Director for Baxter Healthcare’s Europe operations. Prior to that, she was with Rhone Poulenc Rorer as Quality Manager for Sterile Products and Microbiology, in Essex, England. Earlier in her career, she held Quality and Microbiology positions with Berk Pharmaceuticals in East Sussex, England, and Medicines Testing Laboratory, Edinburgh, Scotland.
Ms. Johnson holds a Post Graduate Diploma (PGDip) in Industrial Pharmaceutical Studies with Distinction from Brighton University and has a Bachelor of Science Honours Degree (BSc Hon) in Biological Sciences/Microbiology from North East Surrey College of Technology. She is eligible for nomination as a Qualified Person under the permanent provision of EEC Directive 75/319 and was appointed as a Qualified Person Assessor by the UK Institute of Biology in 1998, currently the Vice Chair of the IOB QP Assessor panel.
John Chiminski, President and Chief Executive Officer of Catalent, said, “I am pleased to welcome Sharon to the Catalent executive team. Her expertise and leadership skills will contribute significantly to extending and continuously improving Catalent’s long track record of product quality and regulatory compliance.” Mr. Chiminski continued, “I also want to recognize Ed Thiele’s many invaluable contributions during his time at Catalent, and wish him well in his forthcoming retirement.” 

About Catalent

Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,500 at more than 30 facilities worldwide and in fiscal 2008 generated more than $1.8 billion in annual revenue. For more information, visit .

more products. better treatments. reliably supplied.™